{
  "title": "Paper_349",
  "abstract": "pmc Sci Rep Sci Rep 1579 scirep Scientific Reports 2045-2322 Nature Publishing Group PMC12484929 PMC12484929.1 12484929 12484929 41028198 10.1038/s41598-025-08631-w 8631 1 Article Nanoparticles of non-porphyrinic covalent organic frameworks as contrast agents for photoacoustic imaging Pi-Martín Irene 1 Vidaurre-Agut Carla 2 Rivero-Buceta Eva María 2 Cebrecos Alejandro alcebrui@upv.es 1 García-Garrigós Juan José jjgarcia@i3m.upv.es 1 Jiménez Noé 1 Benlloch José María 1 Botella Pablo pbotella@itq.upv.es 2 Camarena Francisco 1 1 https://ror.org/03p80e845 grid.507091.a 0000 0004 6478 8116 Instituto de Instrumentación para Imagen Molecular (i3M), Universitat Politècnica de València - Consejo Superior de Investigaciones Científicas, 2 https://ror.org/038792a28 grid.466825.b 0000 0004 1804 7165 Instituto de Tecnología Química, Universitat Politècnica de València - Consejo Superior de Investigaciones Científicas, 30 9 2025 2025 15 478255 33909 26 3 2025 23 6 2025 30 09 2025 02 10 2025 02 10 2025 © The Author(s) 2025 2025 https://creativecommons.org/licenses/by/4.0/ Open Access http://creativecommons.org/licenses/by/4.0/ Photoacoustic imaging (PAI) is an emerging biomedical modality offering non-invasive, high-resolution imaging with molecular contrast. Its effectiveness for molecular imaging is improved by using external contrast agents such as dyes and nanostructures, which enable targeted imaging, deeper tissue penetration, and enhanced diagnostic accuracy. However, the clinical translation of these agents has been hindered by limitations in biocompatibility, biodegradability, and functionalization versatility. In this study, two porphyrin-free nanoscale covalent organic frameworks (nCOFs), TAPB-PDA and LZU-1, were evaluated as novel exogenous contrast agents for PAI. Their photoacoustic responses were systematically measured and compared with traditional contrast agents, such as gold nanoparticles (AuNPs) and ATTO532-labelled mesoporous silica nanoparticles. Experiments at 532 nm across a range of concentrations demonstrated strong photoacoustic signals from TAPB-PDA and LZU-1, with enhanced response at higher concentrations. Besides, both nCOFs also provided detectable signals at the NIR window at the lowest concentration, indicating a broad working range. A nonlinear model of the volume-integrated photoacoustic pressure is also provided. Furthermore, in vitro cytotoxicity assays indicated excellent nCOF biocompatibility, even at higher concentrations. Photostability tests under prolonged pulsed laser irradiation revealed that both nCOFs exhibit good resistance to photobleaching and partial signal recovery under intermittent excitation. Collectively, these findings highlight the potential of TAPB-PDA and LZU-1 nCOFs as biocompatible, biodegradable, and functionally versatile contrast agents for advanced photoacoustic imaging. Keywords Photoacoustic imaging Exogenous contrast agents Covalent organic frameworks Subject terms Nanoparticles Characterization and analytical techniques Imaging techniques https://doi.org/10.13039/501100003359 Generalitat Valenciana CIACIF/2021/403 https://doi.org/10.13039/501100004233 Universitat Politècnica de València PAID-PD-22 https://doi.org/10.13039/501100004837 Ministerio de Ciencia e Innovación IJC2018-037897-I pmc-status-qastatus 0 pmc-status-live yes pmc-status-embargo no pmc-status-released yes pmc-prop-open-access yes pmc-prop-olf no pmc-prop-manuscript no pmc-prop-legally-suppressed no pmc-prop-has-pdf yes pmc-prop-has-supplement yes pmc-prop-pdf-only no pmc-prop-suppress-copyright no pmc-prop-is-real-version no pmc-prop-is-scanned-article no pmc-prop-preprint no pmc-prop-in-epmc yes issue-copyright-statement © Springer Nature Limited 2025 Introduction Photoacoustic imaging (PAI) is an advanced imaging modality with significant applications in the biomedical field, as it enables the acquisition of both functional and molecular information about biological systems, serving as a tool for both diagnosis and treatment monitoring 1 2 3 5 6 Exogenous agents utilized in photoacoustic imaging can be broadly categorized into two main groups 3 7 11 12 22 23 28 29 30 31 32 33 34 Gold and silica nanoparticles have been extensively investigated and even evaluated in human subjects for a range of biomedical applications, including photothermal therapy and targeted drug delivery 35 36 6 37 38 39 40 43 44 45 Consequently, the development of new contrast agents able to promote PAI with high stability in biological fluids, good biocompatibility and a suitable biodegradation profile is needed. In this context, covalent organic frameworks (COFs) are a novel type of materials with topologically ordered columnar \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\pi$$\\end{document} 46 47 In addition, their nature is fully organic (body related), some compositions present strong stability in physiological fluids, they are non-cytotoxic and biodegradable over a wide range of concentrations. Very recently, it has been pointed out that these materials present photoacoustic properties highly dependent on their layered structures 27 48 51 27 52 56 57 In this article, we assess the feasibility of porphyrin-free covalent organic framework nanoparticles (nCOFs) as exogenous contrast agents for PAI. Specifically, nanoparticles of the LZU-1 and TAPB-PDA materials 58 59 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\pi$$\\end{document} Methods Materials All reagents were purchased from commercial suppliers and used without further purification. 1,3,5-Tris(4-aminophenyl) benzene (TAPB), 1,3,5-triformylbenzene (TFB) were purchased from TCI. Terephthaldehyde (PDA), 3-aminopropyltrimethoxysilane (APTMS), ATTO532 and scandium triflate were obtained from Sigma Aldrich. 4-(tert-butoxycarbonylamino)-aniline (NBPDA) was purchased from Fluorochem. Poly(vinylpyrrolidone) (PVP) was acquired from Fluka. Anhydrous acetonitrile (ACN), anhydrous dichloromethane (DCM) and anhydrous toluene were obtained from a solvent purification system (MB SPS-800). AuNPs of 20 nm mean diameter, stabilized in citrate buffer were supplied by Sigma-Aldrich. Synthesis of nanoparticles For the preparation of TAPB-PDA nanoparticles, we followed an optimized recipe from Ref. 25 For the synthesis of LZU-1 nanoparticles, a modified protocol was implemented 59 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$^\\circ$$\\end{document} The preparation of ATTO532 labelled nanoparticles was carried out by post-synthetic modification of mesoporous silica nanoparticles (MSN) 60 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$^\\circ$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\upmu$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$^\\circ$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\upmu$$\\end{document} Characterization of nanoparticles Powder X-ray diffraction (XRD) patterns were collected on a Philips X’Pert diffractometer equipped with a graphite monochromator, operating at 40 kV and 45 mA. Nanoparticle morphology was investigated by transmission electron microscopy (TEM) on a JEOL JEM-1400 Flash microscope operating at 120 kV. The size distribution of the synthesized nanoparticles in aqueous dispersions was determined using a Zetasizer Nano ZS (Malvern Instruments Ltd., Worcestershire, United Kingdom). Here, solutions of dried materials in ACN (nCOFs) or deionized water (MSN-ATTO532) at a concentration of 5 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\upmu$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$^\\circ$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$173^\\circ$$\\end{document} -1 -1 Photoacoustic system The PAI system consists of an Optical Parametric Oscillator (OPO) tunable laser (EKSPLA NT352A, Vilnius, Lithuania), emitting pulses at 10 Hz repetition rate with 6 ns duration, which is synchronized with a Verasonics Vantage 256 TM 1 1 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\hbox {e}^2$$\\end{document} 2 Figure 1 Hybrid PA-US system. ( a b The acquisition system co-registers data to generate hybrid PA-US images using the same US probe, as shown in the inset of Fig. 1 Photoacoustic response at 532 nm Initially, we assess whether the amplitude of the PA response of the proposed organic nanoparticles is comparable to that of a reference standard, namely commercially available gold nanoparticles (AuNPs). The PA response is evaluated in comparison to LZU-1 and TAPB-PDA nCOFs, as well as mesoporous silica nanoparticles labelled with the ATTO532 fluorochrome (MSN-ATTO532), under laser excitation at 532 nm, which corresponds to the peak absorption wavelength of AuNPs and MSN-ATTO532. To ensure consistency, all samples were diluted to a concentration of 0.1 mg/mL, which represents the maximum available concentration for the commercial AuNPs. The baseline PA signal was obtained from measurements conducted on a control sample consisting of a cannula filled with PBS in the absence of nanoparticles. Subsequently, the PA response was evaluated for increasing concentrations (0.1, 0.5, 1, 2, 3, 4, and 5 mg/mL) of LZU-1, TAPB-PDA, and MSN-ATTO532 nanoparticles under excitation at a laser wavelength of 532 nm. It is important to note that the maximum concentration available for the AuNPs was 0.1 mg/mL, hence these samples were not included in this analysis. Additionally, the measured PA signal amplitudes at varying concentrations were fitted to a theoretical model describing the underlying PA effect. Photostability Photostability of all four contrast agents, namely: AuNPs, LZU-1, TAPB-PDA and MSN-ATTO532, was evaluated at a concentration of 0.1 mg/mL using the experimental setup shown in Fig. 1 2 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$A \\exp (-k_1x) + B \\exp (-k_2 x)$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$k = A k_1 + B k_2$$\\end{document} 61 NIR photoacoustic spectroscopy A near-infrared (NIR) photoacoustic spectroscopy analysis was conducted to assess whether these compounds exhibit a sufficient PA response for potential application within the NIR optical window. This spectral region is characterized by reduced light scattering compared to the visible range, thereby enabling greater tissue penetration. For this evaluation, all samples were prepared at a concentration of 0.1 mg/mL, and a laser excitation scan was performed over a wavelength range of 660 nm to 940 nm in increments of 20 nm. Theoretical model of the photoacoustic response In this section, an integrated nonlinear model of the photoacoustic response depending on the light attenuation (absorption and scattering) across a sample volume is derived to provide useful theoretical expressions for general PA experimental measurements. The linear regime approximation of the full model was used as a fitting framework for characterizing the PA response across varying concentrations of nanoparticles. Photoacoustic pressure depending on optical fluence attenuation Photoacoustic measurements are generally performed by recording the signal amplitude from an ultrasonic probe. This amplitude is directly proportional to the laser-induced pressure, generated by rapid thermoelastic expansion that results from the absorption of short optical pulses. Thus, the initial pressure distribution, \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$p_0 (r)$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$r = (x, y, z)$$\\end{document} 1 62 1 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} p_0 (r) = \\Gamma H(r) = \\Gamma \\eta _{th} E_a(r) = \\Gamma \\eta _{th} \\mu _a (r) \\varphi _i (x,y) \\exp (-\\mu^{\\prime}_t z). \\end{aligned}$$\\end{document} H r \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\hbox {m}^3$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\Gamma$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\eta _{th}$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$E_a$$\\end{document} The right-hand side of Eq. ( 1 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mu _a (r)$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\varphi (r,\\mu^{\\prime}_t)$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\varphi _i(x,y)$$\\end{document} z \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mu^{\\prime}_t(r) = \\mu _a(r) + \\mu^{\\prime}_s(r)$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mu^{\\prime}_s = \\mu _s(1-g)$$\\end{document} z \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mu _s$$\\end{document} g \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\hbox {m}^{-1}$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\lambda$$\\end{document} r Photoacoustic measured signal and integrated pressure model For all the experimental tests, the measurement of the PA signal (as outlined in previous sections) is performed as the PA average signal, \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\overline{p}^m_0$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$${p}_0(n)$$\\end{document} N 2 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} \\overline{p}^m_0 = \\frac{1}{N} \\sum _{n=1}^{N} {p}_{0}(n). \\end{aligned}$$\\end{document} 2 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\overline{p}_0$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\hbox {m}^2$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\hbox {m}^3$$\\end{document} S \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\overline{p}^m_0 = S \\overline{p}_0$$\\end{document} Therefore, to obtain the equivalent theoretical model of the average pressure, \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\overline{p}_0$$\\end{document} 1 V 3 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} \\overline{p}_0 = \\frac{1}{V} \\int _V p_0 (r) dr = \\frac{\\Gamma \\eta _{th}}{V} \\int _A \\varphi _i (x,y) dS \\int _0^l \\mu _a \\exp (-\\mu^{\\prime}_t z) dz \\end{aligned}$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\varphi _i (x,y)$$\\end{document} A V \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\overline{E_i}$$\\end{document} l \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\overline{E_i} = \\overline{\\varphi _i}/l$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\hbox {m}^3$$\\end{document} z \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mu^{\\prime}_t$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mu _a$$\\end{document} 4 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mu \\equiv \\overline{\\mu (r)}$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$m_C$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\rho = m_C/V$$\\end{document} Consequently, the average pressure of the laser-excited volume is given as a function of the absorption and extinction coefficients as 4 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} \\overline{p}_0 (\\mu _a, \\mu^{\\prime}_t, l) = \\Gamma \\eta _{th} \\overline{E_i} \\left( \\frac{\\mu _a}{\\mu^{\\prime}_t}\\right) \\left[ 1 - \\exp (-\\mu^{\\prime}_t l)\\right] \\eqsim \\Gamma \\eta _{th} \\overline{\\varphi _i} \\mu _a = \\Gamma \\eta _{th} \\overline{E_i} A. \\end{aligned}$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mu^{\\prime}_t l\\gg 1$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$A_l\\equiv \\mu^{\\prime}_t l$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\overline{p}_0$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\Gamma \\eta _{th} \\overline{E_i} (\\mu _a/\\mu^{\\prime}_t)$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mu _a/(\\mu _a + \\mu^{\\prime}_s)$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mu^{\\prime}_t l<1$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$A_l<1$$\\end{document} 4 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$A_l\\equiv \\mu _a l$$\\end{document} Photoacoustic integrated pressure in terms of molar and mass concentration The equivalent model expression of Eq. ( 4 C \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\rho$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mu = k\\epsilon C = k\\beta \\rho$$\\end{document} k \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$k=\\mathrm {ln(10)}$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$k=1$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\epsilon _a$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\epsilon^{\\prime}_t$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\hbox {cm}^{-1}$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\hbox {mol}^{-1}$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\beta = \\epsilon /M_w$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\hbox {cm}^{-1}$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\hbox {mg}^{-1}$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$M_w$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\rho =CM_w$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\rho$$\\end{document} l 5 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} \\overline{p}_0 (\\rho ,l) = \\Gamma \\eta _{th} \\overline{E_i} \\left( \\frac{\\beta _a}{\\beta^{\\prime}_t}\\right) \\left[ 1-\\exp (-k\\beta^{\\prime}_t \\rho l) \\right] \\eqsim \\Gamma \\eta _{th} \\overline{\\varphi _i} k\\beta _a \\rho , \\end{aligned}$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$A\\equiv \\mu^{\\prime}_t l<1$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$k\\epsilon^{\\prime}_t C l = k \\beta^{\\prime}_t \\rho l<1$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mu _a/\\mu^{\\prime}_t = \\epsilon _a/\\epsilon^{\\prime}_t = \\beta _a/\\beta^{\\prime}_t$$\\end{document} Linear regime approximation for experiments The linear fitting relation used for in our experiments involves the averaged values of pressure with respect to the mass concentration, and is rewritten from Eq. ( 5 6 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} \\overline{p}_0 (\\rho ) = \\alpha _1 \\rho + \\alpha _2. \\end{aligned}$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\alpha _1 = \\Gamma \\eta _{th} \\overline{\\varphi _i} (\\mu _a/\\rho ) = \\Gamma \\eta _{th} \\overline{\\varphi _i} k\\beta _a$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\alpha _2$$\\end{document} 7 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\begin{aligned} \\rho < \\frac{\\Gamma \\eta _{th} \\overline{\\varphi _i}}{\\alpha _1l_s} \\end{aligned}$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mu^{\\prime}_t< \\mu _a < 1/l_s$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\alpha _1$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$l = l_s$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\overline{p}^m_0 (\\rho ) = S \\overline{p}_0(\\rho )$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\alpha _1^m = S \\alpha _1$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\hbox {Vmg}^{-1}$$\\end{document} 7 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\rho < S(\\Gamma \\eta _{th} \\overline{\\varphi _i} / \\alpha ^m_1 l_s)$$\\end{document} Cytotoxicity test The cytotoxic effects of the covalent organic frameworks (COFs) LZU-1 and TAPB-PDA were evaluated using MTS viability assays (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium) in NIH/3T3 (mouse fibroblast) and HeLa (human cervical cancer) cell lines. Both cell lines were purchased from the American Type Culture Collection (ATCC, Rockville, MD). Cells were seeded at a density of 4,000 cells per well in a 96-well plate and cultured in 5% CO2 at 37 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$^\\circ$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mu$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mu$$\\end{document} Results Preparation of stable nanoparticles with high PA response The two types of nCOFs, TAPB-PDA and LZU-1, were synthesized using carefully optimized methods, tailored to each material 25 26 2 2 2 2 -1 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$^{\\circ }$$\\end{document} -1 -1 -1 Figure 2 Characterization of LZU-1 (above) and TAPB-PDA (below) nanoparticles. ( a c b d e f g h MSN-ATTO532 nanoparticles were selected as the reference material due to their comparable size and structural characteristics to the COFs under investigation. These nanoparticles were synthesized as spheroidal monodispersed nanoparticles (Supplementary Fig. S5) with an average diameter of 190 nm, as determined by TEM measurements over 250 particles. However, DLS measurements indicated a slightly larger hydrodynamic average diameter of 255 nm (Supplementary Fig. S1), attributed to the partial formation of dimers and trimers in aqueous medium. The powder XRD measurement showed the typical pattern of a nanoscale MCM-41 phase (Supplementary Fig. S7) 27 2 -1 -1 Photoacoustic validation of nCOFs As shown in Fig. 3 4 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\pi$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\pi$$\\end{document} 63 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\pi$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\pi$$\\end{document} 64 Figure 3 Photoacoustic response of nCOFs. ( a b Figure 3 6 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\alpha _1$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\alpha _2$$\\end{document} 5 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\alpha ^m_1 =$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\alpha _2 = 4.5$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$l_s = 1$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\mu^{\\prime}_t< \\mu _a < 10$$\\end{document} -1 5 The MSN-ATTO532 data were fitted up to a concentration of 4 mg/mL, as the 5 mg/mL sample was identified as an outlier. This anomalously high value is attributable to strong nanoparticle aggregation of the samples, as shown in the TEM image in a high concentration suspension (see Supplementary Fig. S6), this aggregation produced nanoparticles deposition at the bottom of the cannula by gravity, as observed in the PA-US images of the MSN-ATTO532 samples in Fig. S13, and also in the sample photographs in Fig. S10, of the supplementary information. Then, the stronger effect of the 5 mg/mL concentration would lead to adding more nanoparticle’s mass into the cross-sectional window of the cannula used to calculate the integrated PA signal, which may come from other non-imaged sections. This would therefore mean a significant elevation of the average concentration value and the resulting PA signal outlier. Notably, the PA signal response would correspond to a concentration of \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\rho \\eqsim 13$$\\end{document} 6 Photostability The photostability of the four contrast agents, AuNPs, LZU-1, TAPB-PDA, and MSN-ATTO532, was systematically investigated under prolonged pulsed laser excitation at 532 nm. Figure 4 k The lowest photobleaching rate was measured for AuNPs ( \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$k = 4.59 \\times 10^{-5}$$\\end{document} 65 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$k = 1.05 \\times 10^{-4}$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$k = 4.38 \\times 10^{-4}$$\\end{document} 66 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$k = 8.49 \\times 10^{-4}$$\\end{document} 67 Figure 4 Photostability. ( a k b The behavior of the contrast agents under an intermittent excitation protocol, shown in Fig. 4 Overall, the obtained results for AuNPs and MSN-ATTO532 are in line with reported studies 66 68 NIR photoacoustic spectroscopy To assess the potential of the proposed nCOFs within the NIR window, the PA response of the two nCOFs, along with MSN-ATTO532 nanoparticles, was evaluated at a concentration of 0.1 mg/ml, across a wavelength range from 660 to 940 nm at 20 nm increments. Figure 5 Figure 5 NIR spectroscopy. ( a b d e g 2 Figure 5 To quantitatively compare the similarity between the optical and PA spectral curves, a linear regression analysis was performed on the scatter plot, with optical data points plotted on the x-axis and PA experimental data on the y-axis, as shown in Fig. 5 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$R^2$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$R^2$$\\end{document} 5 Cytotoxicity test The in vitro cytotoxicity assays, shown in Fig. 6 69 The purely organic composition of LZU-1 and TAPB-PDA, coupled with the absence of heavy metals, likely contributes to their low toxicity, distinguishing them from conventional inorganic nanoparticles such as gold or silica-based systems. This unique feature underscores the potential of these materials for safe in vivo applications, particularly at higher concentrations, where inorganic nanoparticles often exhibit increased toxicity due to accumulation and oxidative stress. Additionally, the biodegradability of COFs, including LZU-1 and TAPB-PDA, has also been demonstrated in studies showing their gradual degradation under physiological conditions. This process is facilitated by hydrolysis of imine bonds in acidic or enzymatic environments, a hallmark feature of imine-based COFs 70 25 Figure 6 Citotoxicity test. In vitro MTS cell viability assays in HeLa ( a b Discussion The results shown in this work demonstrate that both LZU-1 and TAPB-PDA nanoparticles exhibit significant potential as exogenous contrasts in photoacoustic imaging. At low concentrations (e.g., 0.1 mg/mL), their response is comparable to that of gold nanoparticles (AuNP), although the working wavelength of 532 nm corresponds to the tail absorption region of the nCOFs. More importantly, these nCOFs offer notable advantages over inorganic functionalized nanoparticles (e.g., MSN-ATTO532), primarily due to their highly biocompatible profiles and the absence of leaching of active molecules. Additionally, these nanoparticles are fully biodegradable, with natural elimination routes, primarily through renal and biliary excretion 71 Furthermore, as non-porphyrin-based nCOFs, TAPB-PDA and LZU-1 provide additional biological safety 57 72 3 73 The obtained results also demonstrate the feasibility of utilizing these nCOFs in the NIR window. Not only do they provide detectable signals even at low concentrations (0.1 mg/mL), but, as previously noted, the signal amplitude can be notably enhanced by increasing the nanoparticle concentration. In this regard, the use of nCOFs offers two key advantages. First, since endogenous chromophores, such as haemoglobin, exhibit a reduced light absorption in the NIR window, the proposed nCOFs can be employed to achieve high-contrast photoacoustic imaging without interference from other endogenous contrast agents. Additionally, the reduced light scattering characteristic of the NIR window can enhance photoacoustic imaging penetration, further improving imaging capabilities. One of the main challenges in the engineering of COF structures is shifting their absorbance spectrum into the NIR region, thereby enabling their use in in vivo photothermal and photoacoustic applications 53 74 27 52 56 57 75 76 77 79 In this work we have targeted a distinct approach by exploring the potential of two-dimensional COF structures with closely packed layers and high \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\pi$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\pi$$\\end{document} 63 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\Pi$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\Pi$$\\end{document} 80 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\pi$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\pi$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\pi$$\\end{document} 81 82 \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\pi$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\pi$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\pi$$\\end{document} \\documentclass[12pt]{minimal}\n\t\t\t\t\\usepackage{amsmath}\n\t\t\t\t\\usepackage{wasysym} \n\t\t\t\t\\usepackage{amsfonts} \n\t\t\t\t\\usepackage{amssymb} \n\t\t\t\t\\usepackage{amsbsy}\n\t\t\t\t\\usepackage{mathrsfs}\n\t\t\t\t\\usepackage{upgreek}\n\t\t\t\t\\setlength{\\oddsidemargin}{-69pt}\n\t\t\t\t\\begin{document}$$\\pi$$\\end{document} 83 Conclusion In this study, non-porphyrin-based nano-covalent organic frameworks (nCOFs) were evaluated and experimentally validated as exogenous contrast agents for photoacoustic imaging. Two materials, LZU-1 and TAPB, were analysed and compared against established photoacoustic contrast agents, such as gold nanoparticles and mesoporous silica nanoparticles labelled with the ATTO532 chromophore, which served as baseline references. The results demonstrate that both LZU-1 and TAPB nCOFs produce a photoacoustic response comparable to that of the reference exogenous chromophores at their maximal absorption wavelength of 532 nm. Additionally, the porphyrin-free nature of these nCOFs, combined with their excellent biocompatibility and ease of clearance through natural pathways, makes their use at higher concentrations than inorganic exogenous contrast agents feasible. Consequently, by using larger concentrations (up to 5 mg/mL in this work) their photoacoustic response can be significantly enhanced, leading to improved image contrast and deeper tissue penetration. Furthermore, the potential of these nCOFs in the NIR window was demonstrated through experiments at wavelengths ranging from 660 to 940 nm, revealing PA amplitude levels superior to those of ATTO532-labelled MSN nanoparticles, even at the minimal concentration considered (0.1 mg/mL). These findings demonstrate the capacity of the proposed nCOFs to generate significant PA response across a broad wavelength range. Moreover, these organic materials can be easily functionalized with specific ligands for targeted applications, such as tumour-specific ligands for precise targeting. In addition, photostability assessments under repeated pulsed laser excitation revealed that both LZU-1 and TAPB-PDA exhibit good resistance to photobleaching and partial recovery under intermittent irradiation, reinforcing their suitability for sustained imaging protocols. In conclusion, owing to their enhanced photoacoustic performance, robust biocompatibility and photostability, and versatile design, these nCOFs hold great promise as contrast agents for in vivo photoacoustic imaging, advancing the potential for the clinical translation of molecular photoacoustic imaging technologies. Supplementary Information  Supplementary Information. Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations. Supplementary Information The online version contains supplementary material available at 10.1038/s41598-025-08631-w. Acknowledgements This work has been supported by the Agencia Estatal de Investigación (AEI, projects PID2019111436RBC22 and PID2022142952OB-100), Generalitat Valenciana through the programs Equipamiento e Infraestructuras FEDER 2021-22 IDIFEDER/2021/004, and Programa de Garantía Juvenil I+D EDGJID/2021/189, and NextGenerationEU Recovery and Resilience Facility (RRF) through the PTI+ Global Health Platform of Spanish National Research Council (grant SGL2103023). N. Jiménez is grateful for financial support from the Spanish Ministry of Science, Innovation and Universities (MICIU) through grants “Juan de la Cierva Incorporación”, IJC2018-037897-I, and “Ramón y Cajal” RYC2021-034920-I. A. Cebrecos is grateful for financial support from Universitat Politècnica de València through programs PAID-10-19, PAID-PD-22. Irene Pi is grateful for financial support from program CIACIF/2021/403 of Generalitat Valenciana. In addition, financial support by the Spanish Ministry of Science and Innovation (CEX2021-001230-S grant funded by MCIN/AEI/10.13039/501100011033) is gratefully acknowledged. Author contributions Conceptualization: PB, AC, JJG, FC, NJ, JMB; Methodology: PB, AC, JJG, IP, NJ, FC; Theoretical model: JJG; Investigation and validation: IP, CVA, ERB, AC, JJG, NJ; Formal analysis: IP, CVA, ERB, AC, JJG, NJ; Visualization: IP, PB, AC, JJG, NJ; Funding acquisition: PB, FC, NJ, JMB; Project administration: PB, FC, NJ, JMB; Software: IP, CVA, ERB, AC, JJG, NJ; Supervision: PB, AC, JJG, NJ, FC, JMB; Writing—original draft: IP, PB, AC, JJG, ERB; Writing—review and editing: IP, PB, AC, JJG, NJ, FC, JMB. Data availability Data used in this study will be provided by the corresponding author upon reasonable request. Declarations Competing interests The authors declare no competing interests. References 1. Beard P Biomedical photoacoustic imaging Interface focus 2011 1 602 631 10.1098/rsfs.2011.0028 22866233 PMC3262268 Beard, P. Biomedical photoacoustic imaging. Interface focus 1 22866233 10.1098/rsfs.2011.0028 PMC3262268 2. Park B Park S Kim J Kim C Listening to drug delivery and responses via photoacoustic imaging Adv. Drug Deliv. Rev. 2022 184 114235 10.1016/j.addr.2022.114235 35346776 Park, B., Park, S., Kim, J. & Kim, C. Listening to drug delivery and responses via photoacoustic imaging. Adv. Drug Deliv. Rev. 184 35346776 10.1016/j.addr.2022.114235 3. Weber J Beard PC Bohndiek SE Contrast agents for molecular photoacoustic imaging Nat. Methods 2016 13 639 650 10.1038/nmeth.3929 27467727 Weber, J., Beard, P. C. & Bohndiek, S. E. Contrast agents for molecular photoacoustic imaging. Nat. Methods 13 27467727 10.1038/nmeth.3929 4. Nguyen VP Chain-like gold nanoparticle clusters for multimodal photoacoustic microscopy and optical coherence tomography enhanced molecular imaging Nat. Commun. 2021 12 34 10.1038/s41467-020-20276-z 33397947 PMC7782787 Nguyen, V. P. et al. Chain-like gold nanoparticle clusters for multimodal photoacoustic microscopy and optical coherence tomography enhanced molecular imaging. Nat. Commun. 12 33397947 10.1038/s41467-020-20276-z PMC7782787 5. Xie C Zhen X Lyu Y Pu K Nanoparticle regrowth enhances photoacoustic signals of semiconducting macromolecular probe for in vivo imaging Adv. Mater. 2017 29 1703693 10.1002/adma.201703693 29024155 Xie, C., Zhen, X., Lyu, Y. & Pu, K. Nanoparticle regrowth enhances photoacoustic signals of semiconducting macromolecular probe for in vivo imaging. Adv. Mater. 29 10.1002/adma.201703693 29024155 6. Rastinehad AR Gold nanoshell-localized photothermal ablation of prostate tumors in a clinical pilot device study Proc. Natl. Acad. Sci. 2019 116 18590 18596 10.1073/pnas.1906929116 31451630 PMC6744844 Rastinehad, A. R. et al. Gold nanoshell-localized photothermal ablation of prostate tumors in a clinical pilot device study. Proc. Natl. Acad. Sci. 116 31451630 10.1073/pnas.1906929116 PMC6744844 7. Bhattacharyya S Synthesis and evaluation of near-infrared (nir) dye- herceptin conjugates as photoacoustic computed tomography (pct) probes for her2 expression in breast cancer Bioconjug. Chem. 2008 19 1186 1193 10.1021/bc700482u 18505279 PMC2562750 Bhattacharyya, S. et al. Synthesis and evaluation of near-infrared (nir) dye- herceptin conjugates as photoacoustic computed tomography (pct) probes for her2 expression in breast cancer. Bioconjug. Chem. 19 18505279 10.1021/bc700482u PMC2562750 8. Song KH Stein EW Margenthaler JA Wang LV Noninvasive photoacoustic identification of sentinel lymph nodes containing methylene blue in vivo in a rat model J. Biomed. Opt. 2008 13 054033 054033 10.1117/1.2976427 19021413 PMC2725003 Song, K. H., Stein, E. W., Margenthaler, J. A. & Wang, L. V. Noninvasive photoacoustic identification of sentinel lymph nodes containing methylene blue in vivo in a rat model. J. Biomed. Opt. 13 19021413 10.1117/1.2976427 PMC2725003 9. Chatni MR Tumor glucose metabolism imaged in vivo in small animals with whole-body photoacoustic computed tomography J. Biomed. Opt. 2012 17 076012 076012 10.1117/1.jbo.17.7.076012 22894495 PMC3390466 Chatni, M. R. et al. Tumor glucose metabolism imaged in vivo in small animals with whole-body photoacoustic computed tomography. J. Biomed. Opt. 17 22894495 10.1117/1.JBO.17.7.076012 PMC3390466 10. Onoe S Temma T Kanazaki K Ono M Saji H Development of photostabilized asymmetrical cyanine dyes for in vivo photoacoustic imaging of tumors J. Biomed. Opt. 2015 20 096006 096006 10.1117/1.JBO.20.9.096006 26358819 Onoe, S., Temma, T., Kanazaki, K., Ono, M. & Saji, H. Development of photostabilized asymmetrical cyanine dyes for in vivo photoacoustic imaging of tumors. J. Biomed. Opt. 20 26358819 10.1117/1.JBO.20.9.096006 11. Kim C Song KH Gao F Wang LV Sentinel lymph nodes and lymphatic vessels: noninvasive dual-modality in vivo mapping by using indocyanine green in rats-volumetric spectroscopic photoacoustic imaging and planar fluorescence imaging Radiology 2010 255 442 450 10.1148/radiol.10090281 20413757 PMC2858815 Kim, C., Song, K. H., Gao, F. & Wang, L. V. Sentinel lymph nodes and lymphatic vessels: noninvasive dual-modality in vivo mapping by using indocyanine green in rats-volumetric spectroscopic photoacoustic imaging and planar fluorescence imaging. Radiology 255 20413757 10.1148/radiol.10090281 PMC2858815 12. Mallidi, S., Joshi, P. P., Sokolov, K. & Emelianov, S. On sensitivity of molecular specific photoacoustic imaging using plasmonic gold nanoparticles. In 2009 Annual International Conference of the IEEE Engineering in Medicine and Biology Society 10.1109/IEMBS.2009.5333161 PMC4000720 19964157 13. Mallidi S Larson T Aaron J Sokolov K Emelianov S Molecular specific optoacoustic imaging with plasmonic nanoparticles Opt. Express 2007 15 6583 6588 10.1364/OE.15.006583 19546967 Mallidi, S., Larson, T., Aaron, J., Sokolov, K. & Emelianov, S. Molecular specific optoacoustic imaging with plasmonic nanoparticles. Opt. Express 15 19546967 10.1364/oe.15.006583 14. Mallidi S Multiwavelength photoacoustic imaging and plasmon resonance coupling of gold nanoparticles for selective detection of cancer Nano Lett. 2009 9 2825 2831 10.1021/nl802929u 19572747 PMC2898720 Mallidi, S. et al. Multiwavelength photoacoustic imaging and plasmon resonance coupling of gold nanoparticles for selective detection of cancer. Nano Lett. 9 19572747 10.1021/nl802929u PMC2898720 15. Zhang Q Gold nanoparticles as a contrast agent for in vivo tumor imaging with photoacoustictomography Nanotechnology 2009 20 395102 10.1088/0957-4484/20/39/395102 19726840 Zhang, Q. et al. Gold nanoparticles as a contrast agent for in vivo tumor imaging with photoacoustictomography. Nanotechnology 20 19726840 10.1088/0957-4484/20/39/395102 16. Koga S Distribution and characteristics of transactive response dna binding protein 43 kda pathology in progressive supranuclear palsy Mov. Disord. 2017 32 246 255 10.1002/mds.26809 28009087 PMC5933946 Koga, S. et al. Distribution and characteristics of transactive response dna binding protein 43 kda pathology in progressive supranuclear palsy. Mov. Disord. 32 28009087 10.1002/mds.26809 PMC5933946 17. Jokerst JV Cole AJ Van de Sompel D Gambhir SS Gold nanorods for ovarian cancer detection with photoacoustic imaging and resection guidance via raman imaging in living mice ACS Nano 2012 6 10366 10377 10.1021/nn304347g 23101432 PMC3572720 Jokerst, J. V., Cole, A. J., Van de Sompel, D. & Gambhir, S. S. Gold nanorods for ovarian cancer detection with photoacoustic imaging and resection guidance via raman imaging in living mice. ACS Nano 6 23101432 10.1021/nn304347g PMC3572720 18. Qin H Inflammation-targeted gold nanorods for intravascular photoacoustic imaging detection of matrix metalloproteinase-2 (mmp2) in atherosclerotic plaques. Nanomedicine: Nanotechnology Biol. Med. 2016 12 1765 1774 10.1016/j.nano.2016.02.016 27013129 Qin, H. et al. Inflammation-targeted gold nanorods for intravascular photoacoustic imaging detection of matrix metalloproteinase-2 (mmp2) in atherosclerotic plaques. Nanomedicine: Nanotechnology. Biol. Med. 12 10.1016/j.nano.2016.02.016 27013129 19. Chen H Synthesis and characterization of an hsp27-targeted nanoprobe for in vivo photoacoustic imaging of early nerve injury. Nanomedicine: Nanotechnology Biol. Med. 2016 12 1453 1462 10.1016/j.nano.2016.02.023 27046663 Chen, H. et al. Synthesis and characterization of an hsp27-targeted nanoprobe for in vivo photoacoustic imaging of early nerve injury. Nanomedicine: Nanotechnology. Biol. Med. 12 10.1016/j.nano.2016.02.023 27046663 20. Bao C Gold nanoprisms as optoacoustic signal nanoamplifiers for in vivo bioimaging of gastrointestinal cancers Small 2013 9 68 74 10.1002/smll.201201779 23001862 Bao, C. et al. Gold nanoprisms as optoacoustic signal nanoamplifiers for in vivo bioimaging of gastrointestinal cancers. Small 9 23001862 10.1002/smll.201201779 21. Nie L In vivo volumetric photoacoustic molecular angiography and therapeutic monitoring with targeted plasmonic nanostars Small 2014 10 1585 1593 10.1002/smll.201302924 24150920 Nie, L. et al. In vivo volumetric photoacoustic molecular angiography and therapeutic monitoring with targeted plasmonic nanostars. Small 10 24150920 10.1002/smll.201302924 22. Heidari Z Sariri R Salouti M Gold nanorods-bombesin conjugate as a potential targeted imaging agent for detection of breast cancer J. Photochem. Photobiol., B 2014 130 40 46 10.1016/j.jphotobiol.2013.10.019 24300991 Heidari, Z., Sariri, R. & Salouti, M. Gold nanorods-bombesin conjugate as a potential targeted imaging agent for detection of breast cancer. J. Photochem. Photobiol., B 130 24300991 10.1016/j.jphotobiol.2013.10.019 23. Wang D Etching bulk covalent organic frameworks into nanoparticles of uniform and controllable size by the molecular exchange etching method for sonodynamic and immune combination antitumor therapy Adv. Mater. 2022 34 2205924 10.1002/adma.202205924 36039617 Wang, D. et al. Etching bulk covalent organic frameworks into nanoparticles of uniform and controllable size by the molecular exchange etching method for sonodynamic and immune combination antitumor therapy. Adv. Mater. 34 10.1002/adma.202205924 36039617 24. Sridhar V Designing covalent organic framework-based light-driven microswimmers toward therapeutic applications Adv. Mater. 2023 35 2301126 10.1002/adma.202301126 37003701 PMC11475396 Sridhar, V. et al. Designing covalent organic framework-based light-driven microswimmers toward therapeutic applications. Adv. Mater. 35 37003701 10.1002/adma.202301126 PMC11475396 25. Qin Y Zhu X Huang R Covalent organic frameworks: linkage types, synthetic methods and bio-related applications Biomater. Sci. 2023 11 6942 6976 10.1039/d3bm01247f 37750827 Qin, Y., Zhu, X. & Huang, R. Covalent organic frameworks: linkage types, synthetic methods and bio-related applications. Biomater. Sci. 11 37750827 10.1039/d3bm01247f 26. Chen J Composite materials based on covalent organic frameworks for multiple advanced applications In Exploration 2023 3 20220144 10.1002/EXP.20220144 PMC10624394 37933382 Chen, J. et al. Composite materials based on covalent organic frameworks for multiple advanced applications. In Exploration 3 (Wiley Online Library) 10.1002/EXP.20220144 PMC10624394 37933382 27. Wang D Porphyrin-based covalent organic framework nanoparticles for photoacoustic imaging-guided photodynamic and photothermal combination cancer therapy Biomaterials 2019 223 119459 10.1016/j.biomaterials.2019.119459 31499253 Wang, D. et al. Porphyrin-based covalent organic framework nanoparticles for photoacoustic imaging-guided photodynamic and photothermal combination cancer therapy. Biomaterials 223 31499253 10.1016/j.biomaterials.2019.119459 28. Zhu Y Construction of interlayer conjugated links in 2d covalent organic frameworks via topological polymerization J. Am. Chem. Soc. 2021 143 7897 7902 10.1021/jacs.1c02932 34009971 Zhu, Y. et al. Construction of interlayer conjugated links in 2d covalent organic frameworks via topological polymerization. J. Am. Chem. Soc. 143 34009971 10.1021/jacs.1c02932 29. Yang X Stein EW Ashkenazi S Wang LV Nanoparticles for photoacoustic imaging Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 2009 1 360 368 10.1002/wnan.42 20049803 Yang, X., Stein, E. W., Ashkenazi, S. & Wang, L. V. Nanoparticles for photoacoustic imaging. Wiley Interdiscip. Rev. Nanomed. Nanobiotechnol. 1 20049803 10.1002/wnan.42 30. Tsai C-L Chen J-C Wang W-J Near-infrared absorption property of biological soft tissue constituents J. Med. Biol. Eng. 2001 21 7 14 Tsai, C.-L., Chen, J.-C. & Wang, W.-J. Near-infrared absorption property of biological soft tissue constituents. J. Med. Biol. Eng. 21 31. Zhong J Yang S Contrast-enhanced photoacoustic imaging using indocyanine green-containing nanoparticles J. Innov. Opt. Health Sci. 2014 7 1350029 10.1142/S1793545813500296 Zhong, J. & Yang, S. Contrast-enhanced photoacoustic imaging using indocyanine green-containing nanoparticles. J. Innov. Opt. Health Sci. 7 32. Sykes EA Chen J Zheng G Chan WC Investigating the impact of nanoparticle size on active and passive tumor targeting efficiency ACS Nano 2014 8 5696 5706 10.1021/nn500299p 24821383 Sykes, E. A., Chen, J., Zheng, G. & Chan, W. C. Investigating the impact of nanoparticle size on active and passive tumor targeting efficiency. ACS Nano 8 24821383 10.1021/nn500299p 33. Wilson K Homan K Emelianov S Biomedical photoacoustics beyond thermal expansion using triggered nanodroplet vaporization for contrast-enhanced imaging Nat. Commun. 2012 3 618 10.1038/ncomms1627 22233628 Wilson, K., Homan, K. & Emelianov, S. Biomedical photoacoustics beyond thermal expansion using triggered nanodroplet vaporization for contrast-enhanced imaging. Nat. Commun. 3 22233628 10.1038/ncomms1627 34. Fu Q Zhu R Song J Yang H Chen X Photoacoustic imaging: contrast agents and their biomedical applications Adv. Mater. 2019 31 1805875 10.1002/adma.201805875 30556205 Fu, Q., Zhu, R., Song, J., Yang, H. & Chen, X. Photoacoustic imaging: contrast agents and their biomedical applications. Adv. Mater. 31 10.1002/adma.201805875 30556205 35. Tiwari PM Vig K Dennis VA Singh SR Functionalized gold nanoparticles and their biomedical applications Nanomaterials 2011 1 31 63 10.3390/nano1010031 28348279 PMC5315048 Tiwari, P. M., Vig, K., Dennis, V. A. & Singh, S. R. Functionalized gold nanoparticles and their biomedical applications. Nanomaterials 1 28348279 10.3390/nano1010031 PMC5315048 36. Zhang R Kiessling F Lammers T Pallares RM Clinical translation of gold nanoparticles Drug Deliv. Transl. Res. 2023 13 378 385 10.1007/S13346-022-01232-4 36045273 PMC9432795 Zhang, R., Kiessling, F., Lammers, T. & Pallares, R. M. Clinical translation of gold nanoparticles. Drug Deliv. Transl. Res. 13 36045273 10.1007/s13346-022-01232-4 PMC9432795 37. Alle M Sharma G Lee S-H Kim J-C Next-generation engineered nanogold for multimodal cancer therapy and imaging: a clinical perspectives J. Nanobiotechnol. 2022 20 222 10.1186/s12951-022-01402-z PMC9250257 35778747 Alle, M., Sharma, G., Lee, S.-H. & Kim, J.-C. Next-generation engineered nanogold for multimodal cancer therapy and imaging: a clinical perspectives. J. Nanobiotechnol. 20 10.1186/s12951-022-01402-z PMC9250257 35778747 38. Xu B Li S Shi R Liu H Multifunctional mesoporous silica nanoparticles for biomedical applications Signal Transduct. Target. Ther. 2023 8 435 10.1038/s41392-023-01654-7 37996406 PMC10667354 Xu, B., Li, S., Shi, R. & Liu, H. Multifunctional mesoporous silica nanoparticles for biomedical applications. Signal Transduct. Target. Ther. 8 37996406 10.1038/s41392-023-01654-7 PMC10667354 39. Janjua TI Silica nanoparticles: A review of their safety and current strategies to overcome biological barriers Adv. Drug Deliv. Rev. 2023 203 115115 10.1016/j.addr.2023.115115 37844843 Janjua, T. I. et al. Silica nanoparticles: A review of their safety and current strategies to overcome biological barriers. Adv. Drug Deliv. Rev. 203 37844843 10.1016/j.addr.2023.115115 40. Manke A Wang L Rojanasakul Y Mechanisms of nanoparticle-induced oxidative stress and toxicity Biomed. Res. Int. 2013 2013 942916 10.1155/2013/942916 24027766 PMC3762079 Manke, A., Wang, L. & Rojanasakul, Y. Mechanisms of nanoparticle-induced oxidative stress and toxicity. Biomed. Res. Int. 2013 24027766 10.1155/2013/942916 PMC3762079 41. Hariri A Molecular imaging of oxidative stress using an led-based photoacoustic imaging system Sci. Rep. 2019 9 11378 10.1038/s41598-019-47599-2 31388020 PMC6684596 Hariri, A. et al. Molecular imaging of oxidative stress using an led-based photoacoustic imaging system. Sci. Rep. 9 31388020 10.1038/s41598-019-47599-2 PMC6684596 42. Pan Y Gold nanoparticles of diameter 1.4 nm trigger necrosis by oxidative stress and mitochondrial damage Small 2009 5 2067 2076 10.1002/smll.200900466 19642089 Pan, Y. et al. Gold nanoparticles of diameter 1.4 nm trigger necrosis by oxidative stress and mitochondrial damage. Small 5 19642089 10.1002/smll.200900466 43. Li JJ Hartono D Ong C-N Bay B-H Yung L-YL Autophagy and oxidative stress associated with gold nanoparticles Biomaterials 2010 31 5996 6003 10.1016/j.biomaterials.2010.04.014 20466420 Li, J. J., Hartono, D., Ong, C.-N., Bay, B.-H. & Yung, L.-Y.L. Autophagy and oxidative stress associated with gold nanoparticles. Biomaterials 31 20466420 10.1016/j.biomaterials.2010.04.014 44. Niżnik Ł Gold nanoparticles (aunps)-toxicity, safety and green synthesis: A critical review Int. J. Mol. Sci. 2024 25 4057 10.3390/ijms25074057 38612865 PMC11012566 Niżnik, Ł et al. Gold nanoparticles (aunps)-toxicity, safety and green synthesis: A critical review. Int. J. Mol. Sci. 25 38612865 10.3390/ijms25074057 PMC11012566 45. Jakic, K. et al. Long-term accumulation, biological effects and toxicity of bsa-coated gold nanoparticles in the mouse liver, spleen, and kidneys. Int. J. Nanomed. 10.2147/IJN.S443168 PMC11088863 38736658 46. Cote AP Porous, crystalline, covalent organic frameworks Science 2005 310 1166 1170 10.1126/science.1120411 16293756 Cote, A. P. et al. Porous, crystalline, covalent organic frameworks. Science 310 16293756 10.1126/science.1120411 47. Jiménez-Almarza A Imine-based covalent organic frameworks as photocatalysts for metal free oxidation processes under visible light conditions ChemCatChem 2019 11 4916 4922 10.1002/cctc.201901061 Jiménez-Almarza, A. et al. Imine-based covalent organic frameworks as photocatalysts for metal free oxidation processes under visible light conditions. ChemCatChem 11 48. Guan Q Bodipy-decorated nanoscale covalent organic frameworks for photodynamic therapy IScience 2019 14 180 198 10.1016/j.isci.2019.03.028 30981114 PMC6461589 Guan, Q. et al. Bodipy-decorated nanoscale covalent organic frameworks for photodynamic therapy. IScience 14 30981114 10.1016/j.isci.2019.03.028 PMC6461589 49. Mi Z Stable radical cation-containing covalent organic frameworks exhibiting remarkable structure-enhanced photothermal conversion J. Am. Chem. Soc. 2019 141 14433 14442 10.1021/jacs.9b07695 31426635 Mi, Z. et al. Stable radical cation-containing covalent organic frameworks exhibiting remarkable structure-enhanced photothermal conversion. J. Am. Chem. Soc. 141 31426635 10.1021/jacs.9b07695 50. Feng J Core-shell-structured covalent-organic framework as a nanoagent for single-laser-induced phototherapy ACS Appl. Mater. Interfaces 2021 13 17243 17254 10.1021/acsami.1c01125 33825447 Feng, J. et al. Core-shell-structured covalent-organic framework as a nanoagent for single-laser-induced phototherapy. ACS Appl. Mater. Interfaces 13 33825447 10.1021/acsami.1c01125 51. Guan Q Zhou L-L Li W-Y Li Y-A Dong Y-B Covalent organic frameworks (cofs) for cancer therapeutics Chem. A Eur. J. 2020 26 5583 5591 10.1002/chem.201905150 31880368 Guan, Q., Zhou, L.-L., Li, W.-Y., Li, Y.-A. & Dong, Y.-B. Covalent organic frameworks (cofs) for cancer therapeutics. Chem. A Eur. J. 26 10.1002/chem.201905150 31880368 52. Feng J Covalent organic framework-based nanomotor for multimodal cancer photo-theranostics Adv. Healthcare Mater. 2023 12 2301645 10.1002/adhm.202301645 37557883 Feng, J. et al. Covalent organic framework-based nanomotor for multimodal cancer photo-theranostics. Adv. Healthcare Mater. 12 10.1002/adhm.202301645 37557883 53. Zhang X Rationally designed benzobisthiadiazole-based covalent organic framework for high-performance nir-ii fluorescence imaging-guided photodynamic therapy Adv. Healthc. Mater. 2024 13 2303842 10.1002/adhm.202303842 38458147 Zhang, X. et al. Rationally designed benzobisthiadiazole-based covalent organic framework for high-performance nir-ii fluorescence imaging-guided photodynamic therapy. Adv. Healthc. Mater. 13 10.1002/adhm.202303842 38458147 54. Wan X A covalent organic framework derived n-doped carbon nanozyme as the all-rounder for targeted catalytic therapy and nir-ii photothermal therapy of cancer ACS Appl. Mater. Interfaces 2023 15 44763 44772 10.1021/acsami.3c09614 37712575 Wan, X. et al. A covalent organic framework derived n-doped carbon nanozyme as the all-rounder for targeted catalytic therapy and nir-ii photothermal therapy of cancer. ACS Appl. Mater. Interfaces 15 37712575 10.1021/acsami.3c09614 55. Yang G-P Construction of d-a-conjugated covalent organic frameworks with enhanced photodynamic, photothermal, and nanozymatic activities for efficient bacterial inhibition ACS Appl. Mater. Interfaces 2022 14 28289 28300 10.1021/acsami.2c05953 35675646 Yang, G.-P. et al. Construction of d-a-conjugated covalent organic frameworks with enhanced photodynamic, photothermal, and nanozymatic activities for efficient bacterial inhibition. ACS Appl. Mater. Interfaces 14 35675646 10.1021/acsami.2c05953 56. Gao P A cof-based nanoplatform for highly efficient cancer diagnosis, photodynamic therapy and prognosis Chem. Sci. 2020 11 6882 6888 10.1039/d0sc00847h 33033601 PMC7500084 Gao, P. et al. A cof-based nanoplatform for highly efficient cancer diagnosis, photodynamic therapy and prognosis. Chem. Sci. 11 33033601 10.1039/d0sc00847h PMC7500084 57. Brugna M Tasse L Hederstedt L In vivo production of catalase containing haem analogues FEBS J. 2010 277 2663 2672 10.1111/j.1742-4658.2010.07677.x 20553500 Brugna, M., Tasse, L. & Hederstedt, L. In vivo production of catalase containing haem analogues. FEBS J. 277 20553500 10.1111/j.1742-464X.2010.07677.x 58. Li RL Controlled growth of imine-linked two-dimensional covalent organic framework nanoparticles Chem. Sci. 2019 10 3796 3801 10.1039/c9sc00289h 30996969 PMC6446964 Li, R. L. et al. Controlled growth of imine-linked two-dimensional covalent organic framework nanoparticles. Chem. Sci. 10 30996969 10.1039/c9sc00289h PMC6446964 59. Ding S-Y Construction of covalent organic framework for catalysis: Pd/cof-lzu1 in suzuki-miyaura coupling reaction J. Am. Chem. Soc. 2011 133 19816 19822 10.1021/ja206846p 22026454 Ding, S.-Y. et al. Construction of covalent organic framework for catalysis: Pd/cof-lzu1 in suzuki-miyaura coupling reaction. J. Am. Chem. Soc. 133 22026454 10.1021/ja206846p 60. Macchione MA Bedoya DA Rivero-Buceta E Botella P Strumia MC Mesoporous silica and oligo (ethylene glycol) methacrylates-based dual-responsive hybrid nanogels Nanomaterials 2022 12 3835 10.3390/nano12213835 36364611 PMC9657937 Macchione, M. A., Bedoya, D. A., Rivero-Buceta, E., Botella, P. & Strumia, M. C. Mesoporous silica and oligo (ethylene glycol) methacrylates-based dual-responsive hybrid nanogels. Nanomaterials 12 36364611 10.3390/nano12213835 PMC9657937 61. Gao L Wang L Li C García-Uribe A Wang LV Photothermal bleaching in time-lapse photoacoustic microscopy J. Biophotonics 2013 6 543 548 10.1002/jbio.201200184 23184422 PMC3901079 Gao, L., Wang, L., Li, C., García-Uribe, A. & Wang, L. V. Photothermal bleaching in time-lapse photoacoustic microscopy. J. Biophotonics 6 23184422 10.1002/jbio.201200184 PMC3901079 62. Wang LV Wu H-I Biomed. Opt. Principles Imaging 2007 John Wiley & Sons Wang, L. V. & Wu, H.-I. Biomed. Opt. Principles Imaging 63. Tan J Manipulation of amorphous-to-crystalline transformation: Towards the construction of covalent organic framework hybrid microspheres with nir photothermal conversion ability Angew. Chem. Int. Ed. 2016 55 13979 13984 10.1002/ange.201606155 27709769 Tan, J. et al. Manipulation of amorphous-to-crystalline transformation: Towards the construction of covalent organic framework hybrid microspheres with nir photothermal conversion ability. Angew. Chem. Int. Ed. 55 10.1002/anie.201606155 27709769 64. Dalapati S Jin E Addicoat M Heine T Jiang D Highly emissive covalent organic frameworks J. Am. Chem. Soc. 2016 138 5797 5800 10.1021/jacs.6b02700 27108740 Dalapati, S., Jin, E., Addicoat, M., Heine, T. & Jiang, D. Highly emissive covalent organic frameworks. J. Am. Chem. Soc. 138 27108740 10.1021/jacs.6b02700 65. Barlow BR Kim J Next generation gold nanomaterials for photoacoustic imaging Nanomedicine 2025 20 1479 1493 10.1080/17435889.2025.2504330 40356229 PMC12143679 Barlow, B. R. & Kim, J. Next generation gold nanomaterials for photoacoustic imaging. Nanomedicine 20 40356229 10.1080/17435889.2025.2504330 PMC12143679 66. Pu K Semiconducting polymer nanoparticles as photoacoustic molecular imaging probes in living mice Nat. Nanotechnol. 2014 9 233 239 10.1038/nnano.2013.302 24463363 PMC3947658 Pu, K. et al. Semiconducting polymer nanoparticles as photoacoustic molecular imaging probes in living mice. Nat. Nanotechnol. 9 24463363 10.1038/nnano.2013.302 PMC3947658 67. Stahl T Allen T Beard P Characterization of the thermalisation efficiency and photostability of photoacoustic contrast agents Proc. SPIE, Photons Plus Ultrasound: Imaging and Sensing 2014 2014 8943 830 837 10.1117/12.2039694 Stahl, T., Allen, T. & Beard, P. Characterization of the thermalisation efficiency and photostability of photoacoustic contrast agents. Proc. SPIE, Photons Plus Ultrasound: Imaging and Sensing 2014 8943 68. Chen YS Enhanced thermal stability of silica-coated gold nanorods for photoacoustic imaging and image-guided therapy Opt. Express 2010 18 8867 8878 10.1364/OE.18.008867 20588732 PMC3404861 Chen, Y. S. et al. Enhanced thermal stability of silica-coated gold nanorods for photoacoustic imaging and image-guided therapy. Opt. Express 18 20588732 10.1364/OE.18.008867 PMC3404861 69. Bai L Nanoscale covalent organic frameworks as smart carriers for drug delivery Chem. Commun. 2016 52 4128 4131 10.1039/c6cc00853d 26877025 Bai, L. et al. Nanoscale covalent organic frameworks as smart carriers for drug delivery. Chem. Commun. 52 10.1039/c6cc00853d 26877025 70. Mokhtari N Dinari M Khosravi Esmaeiltarkhani F Imine-linked covalent organic frameworks: A biocompatible and ph-dependent carrier for in vitro sustained release of doxorubicin ACS Omega 2023 8 25565 25573 10.1021/acsomega.3c03316 37483239 PMC10357574 Mokhtari, N., Dinari, M. & Khosravi Esmaeiltarkhani, F. Imine-linked covalent organic frameworks: A biocompatible and ph-dependent carrier for in vitro sustained release of doxorubicin. ACS Omega 8 37483239 10.1021/acsomega.3c03316 PMC10357574 71. Guo H Liu Y Wu N Sun L Yang W Covalent organic frameworks (cofs): a necessary choice for drug delivery ChemistrySelect 2022 7 e202202538 10.1002/slct.202202538 Guo, H., Liu, Y., Wu, N., Sun, L. & Yang, W. Covalent organic frameworks (cofs): a necessary choice for drug delivery. ChemistrySelect 7 72. Maitra D Porphyrin-induced protein oxidation and aggregation as a mechanism of porphyria-associated cell injury Cell. Mol. Gastroenterol. Hepatol. 2019 8 535 548 10.1016/j.jcmgh.2019.06.006 31233899 PMC6820234 Maitra, D. et al. Porphyrin-induced protein oxidation and aggregation as a mechanism of porphyria-associated cell injury. Cell. Mol. Gastroenterol. Hepatol. 8 31233899 10.1016/j.jcmgh.2019.06.006 PMC6820234 73. Liu Y Hypoxia-triggered degradable porphyrinic covalent organic framework for synergetic photodynamic and photothermal therapy of cancer Mater. Today Biol. 2024 25 100981 10.1016/j.mtbio.2024.100981 PMC10865025 38356961 Liu, Y. et al. Hypoxia-triggered degradable porphyrinic covalent organic framework for synergetic photodynamic and photothermal therapy of cancer. Mater. Today Biol. 25 10.1016/j.mtbio.2024.100981 PMC10865025 38356961 74. Guo J Kong S Lian Y Zhao M Recent bio-applications of covalent organic framework-based nanomaterials Chem. Commun. 2024 60 918 934 10.1039/d3cc04368a 38168699 Guo, J., Kong, S., Lian, Y. & Zhao, M. Recent bio-applications of covalent organic framework-based nanomaterials. Chem. Commun. 60 10.1039/d3cc04368a 38168699 75. Liu X Zhao F Ming S Zhang Y Zhao J Construction of two-dimensional porous polymers with crystalline or amorphous forms for near-infrared electrochromism Eur. Polymer J. 2024 208 112853 10.1016/j.eurpolymj.2024.112853 Liu, X., Zhao, F., Ming, S., Zhang, Y. & Zhao, J. Construction of two-dimensional porous polymers with crystalline or amorphous forms for near-infrared electrochromism. Eur. Polymer J. 208 76. Hao Q A covalent organic framework film for three-state near-infrared electrochromism and a molecular logic gate Angew. Chem. 2021 133 12606 12611 10.1002/anie.202100870 33756014 Hao, Q. et al. A covalent organic framework film for three-state near-infrared electrochromism and a molecular logic gate. Angew. Chem. 133 10.1002/anie.202100870 33756014 77. Thankachan D Enhanced tumor targeting with near-infrared light-activated indocyanine green encapsulated in covalent organic framework for combined photodynamic therapy (pdt) and photothermal therapy (ptt) Dyes Pigm. 2024 221 111812 10.1016/j.dyepig.2023.111812 Thankachan, D. et al. Enhanced tumor targeting with near-infrared light-activated indocyanine green encapsulated in covalent organic framework for combined photodynamic therapy (pdt) and photothermal therapy (ptt). Dyes Pigm. 221 78. Zhao K Size-controllable covalent organic frameworks with high nir absorption for targeted delivery of glucose oxidase J. Mol. Liq. 2022 346 117896 10.1016/j.molliq.2021.117896 Zhao, K. et al. Size-controllable covalent organic frameworks with high nir absorption for targeted delivery of glucose oxidase. J. Mol. Liq. 346 79. Guan Q Nanoscale covalent organic framework for combinatorial antitumor photodynamic and photothermal therapy ACS Nano 2019 13 13304 13316 10.1021/acsnano.9b06467 31689082 Guan, Q. et al. Nanoscale covalent organic framework for combinatorial antitumor photodynamic and photothermal therapy. ACS Nano 13 31689082 10.1021/acsnano.9b06467 80. Karl Haug W Moscarello EM Wolfson ER McGrier PL The luminescent and photophysical properties of covalent organic frameworks Chem. Soc. Rev. 2019 49 839 864 10.1039/c9cs00807a 31957763 Karl Haug, W., Moscarello, E. M., Wolfson, E. R. & McGrier, P. L. The luminescent and photophysical properties of covalent organic frameworks. Chem. Soc. Rev. 49 10.1039/c9cs00807a 31957763 81. Wang Y Linkages make a difference in the photoluminescence of covalent organic frameworks Angew. Chem. Int. Ed. 2023 62 e202310794 10.1002/anie.202310794 37596246 Wang, Y. et al. Linkages make a difference in the photoluminescence of covalent organic frameworks. Angew. Chem. Int. Ed. 62 10.1002/anie.202310794 37596246 82. Bodin JB Fine Tuning of the Photoacoustic Generation Efficiency by Aggregation-Caused Quenching and Excitation Energy Transfer in Bodipy-Labeled Polylactide Nanoparticles J. Phys. Chem. C 2023 127 18971 18985 10.1021/acs.jpcc.3c03500 Bodin, J. B. et al. Fine Tuning of the Photoacoustic Generation Efficiency by Aggregation-Caused Quenching and Excitation Energy Transfer in Bodipy-Labeled Polylactide Nanoparticles. J. Phys. Chem. C 127 83. Checa-Chavarria E Development of a Prodrug of Camptothecin for Enhanced Treatment of Glioblastoma Multiforme Mol. Pharm. 2021 18 1558 1572 10.1021/acs.molpharmaceut.0c00968 33645231 PMC8482753 Checa-Chavarria, E. et al. Development of a Prodrug of Camptothecin for Enhanced Treatment of Glioblastoma Multiforme. Mol. Pharm. 18 33645231 10.1021/acs.molpharmaceut.0c00968 PMC8482753 ",
  "metadata": {
    "Title of this paper": "Development of a Prodrug of Camptothecin for Enhanced Treatment of Glioblastoma Multiforme",
    "Journal it was published in:": "Scientific Reports",
    "URL": "https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12484929/"
  }
}